021-51111890
购物车（）
sales@molnova.cn
Glycogen phosphorylase-IN-1
CAS No. 648926-15-2
Glycogen phosphorylase-IN-1 ( —— )
产品货号. M34962 CAS No. 648926-15-2
Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥2959 | 有现货 |
|
| 5MG | ￥5556 | 有现货 |
|
| 10MG | ￥7938 | 有现货 |
|
| 25MG | ￥11417 | 有现货 |
|
| 50MG | ￥15327 | 有现货 |
|
| 100MG | ￥20273 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Glycogen phosphorylase-IN-1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.
-
产品描述Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Phosphorylase
-
研究领域——
-
适应症——
化学信息
-
CAS Number648926-15-2
-
分子量412.78
-
分子式C17H15ClF2N4O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(NC(=O)C1=CC(F)=C(F)C=C1Cl)NC2=CC(=CC=C2OC)NC(=O)NC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
R-E-D-V
REDV 是纤连蛋白交替剪接的 III 型连接段 (IIICS) 区域的 CS5 位点内的最小活性序列。REDV 可以通过结合整合素 α4β1 介导与血浆纤连 IIICS 区域的粘附。REDV 可用于细胞粘附的研究。
-
RORγ inverse agonist...
RORγ inverse agonist 1 是 RORγ 的反向激动剂。
-
Amyloid Bri Protein ...
Amyloid Bri Protein Precursor277 (89-106)
